Introduction

The realisation that NF- kappaB activity is regulated by kinases and ubiquitin modifying enzymes presents multiple opportunities for therapeutic intervention. In addition to highlights from basic research, results from clinical trials using IKK and other NF- kappaB inhibitors are expected to be presented at this meeting.

Venue

Eldorado Hotel & Spa

Eldorado Hotel & Spa, Santa Fe, New Mexico, United States

Organised by

Michelle A. Kelliher, Manolis Pasparakis and Jürg Tschopp

Contact information

Keystone Symposia on Molecular and Cellular Biology
United States of America
1-970-262-1230
Contact us by email

---